-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Every September is World Alzheimer’s Disease Month.
Every September is World Alzheimer’s Disease Month.
This event invited Liu Jun, the director of the Department of Geriatric Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Zou Haiqiang, deputy director of the Department of Neurosurgery, Southern Theater General Hospital of the PLA, Guo Aihua, deputy director of the Department of Neurology, Guangzhou First People's Hospital, and the Department of Geriatric Psychiatry, Affiliated Brain Hospital of Guangzhou Medical University Deputy Director Yu Junchang explained the related knowledge of Alzheimer's disease, and was introduced by Zeng Xiaojing, chairman of the Hongmian Public Welfare Foundation (Guangzhou Kapok Tumor and Rare Disease Public Welfare Foundation).
Picture: "Jiu Jiu Caring" Alzheimer's Disease Public Welfare Science Activity Site
Picture: "Jiu Jiu Caring" Alzheimer's Disease Public Welfare Science Activity SiteReduce the burden of medication for patients to achieve long-term benefits
Reduce the burden on patients to achieve long-term benefits Reduce the burden on patients to achieve long-term benefitsAt the International Alzheimer's Month in September, the serious situation facing the disease attracted attention
At the International Alzheimer's Month in September, the serious situation facing the disease attracted attention
According to the “Reevaluation of the Burden of Alzheimer’s Disease in China and Worldwide” published by Professor Jia Jianping’s team from Xuanwu Hospital of Capital Medical University in April 2018, China’s Alzheimer’s disease patients cost an average of 130,000 per person per year.
In order to help many patients with mild to moderate Alzheimer’s disease and cognitive dysfunction to reduce their financial burden and improve their quality of life, the China Primary Health Care Foundation and the Hongmian Foundation sponsored the launch of the "Jiu Jiu Care-Alz Charity Aid Project for Patients with Haimer Disease", supported by Beijing Yuanxin Technology Group and Supai Health Technology, Shanghai Green Valley Pharmaceutical Co.
Picture: On-site sharing by Zeng Xiaojing, Chairman of the Hongmian Public Welfare Foundation
Picture: On-site sharing by Zeng Xiaojing, Chairman of the Hongmian Public Welfare Foundation“A guideline issued by the National Health and Construction Commission pointed out that the principle of treatment of Alzheimer’s disease is early diagnosis, timely treatment, and life-long management to delay the development of the disease
“A guideline issued by the National Health and Construction Commission pointed out that the principle of treatment of Alzheimer’s disease is early diagnosis, timely treatment, and life-long management to delay the development of the disease
The "Jiu Jiu Care" project was officially launched nationwide in April.
Early detection, adherence to treatment, and family care are vital to the treatment of patients who have been diagnosed.
Alzheimer's disease " early detection and wisdom " without delay Alzheimer's disease , " early detection and wisdom " without delay
According to data from the International Alzheimer's Association (ADI), a patient with dementia occurs every 3 seconds in the world, and two-thirds of people believe that dementia is a natural process of aging.
According to data from the International Alzheimer's Association (ADI), a patient with dementia occurs every 3 seconds in the world, and two-thirds of people believe that dementia is a natural process of aging.
The theme of this year’s International Alzheimer’s Disease Month is "Know your neighbors and confidants, early diagnosis and early wisdom".
The International Alzheimer’s Association has given guidelines on how to “know the enemy and confidant, early diagnosis and early wisdom”, including the ten major early symptoms of dementia warnings: not knowing the time and place, not doing familiar work, Withdrawal from work or social activities, memory loss, difficulty in understanding visual and spatial information, loss of language ability, changes in mood and behavior, misplacement of things, loss of thinking and judgment, and difficulty in grasping the progress of work
"Alzheimer's disease is preventable and
"Treatment is required as soon as diagnosis, and lifelong medication is required once treatment
.
" said Zou Haiqiang, deputy director of the Department of Neurosurgery at the General Hospital of the PLA Southern Theater Command
.
As one of the most common degenerative diseases of the central nervous system, Alzheimer’s disease has a long course, complex pathological mechanisms, and multiple high-risk factors involved in the pathogenesis.
The current mainstream mechanism hypotheses include the Aβ hypothesis, neurotransmitter hypothesis, and tau transmission.
Hypothesis
.
In recent years, more and more theoretical studies and discoveries have shown that the intestinal flora plays an important role in the occurrence and development of many major and complex diseases
.
Following breakthroughs in the study of the brain-gut axis in Parkinson's disease and other fields, the relationship between intestinal flora and Alzheimer's disease has gradually been revealed
.
On November 2, 2019, the ninth phase 1 of the domestically-produced original research drug for the brain-gut axis mechanism was officially approved, bringing new treatment options and new hope to patients
.
The current mainstream mechanism hypotheses include the Aβ hypothesis, neurotransmitter hypothesis, and tau transmission.
Hypothesis
.
In recent years, more and more theoretical studies and discoveries have shown that the intestinal flora plays an important role in the occurrence and development of many major and complex diseases
.
Following breakthroughs in the study of the brain-gut axis in Parkinson's disease and other fields, the relationship between intestinal flora and Alzheimer's disease has gradually been revealed
.
On November 2, 2019, the ninth phase 1 of the domestically-produced original research drug for the brain-gut axis mechanism was officially approved, bringing new treatment options and new hope to patients
.
About "Jiu Jiu Care-Charity Aid Project for Alzheimer's Disease Patients"
About "Jiu Jiu Care-Charity Aid Project for Alzheimer's Disease Patients" About "Jiu Jiu Care-Charity Aid Project for Alzheimer's Disease Patients" "Long Nine Care-Charity Assistance Project for Alzheimer's Disease Patients" is sponsored by China Primary Health Care Foundation and Hongmian Public Welfare Foundation, supported by Beijing Yuanxin Technology Group and Supai Health Technology, and provided free of charge by Shanghai Green Valley Pharmaceutical Co.
, Ltd.
Aid medicine Mannote Sodium Capsules (trade name: Jiu Phase One®)
.
The patients who meet the corresponding application conditions were reviewed and enrolled in the group.
After the doctor’s advice, they used 24 boxes (6 months dosage) of Nine Phase One® for treatment.
All the materials were reviewed and approved by the foundation, and they can support up to 12 boxes (3 months dosage).
The ninth phase 1 ® is divided into 3 times for assistance, which can be picked up at the designated stores of the National Center of Pharmacy and Sipai Pharmacy
.
, Ltd.
Aid medicine Mannote Sodium Capsules (trade name: Jiu Phase One®)
.
The patients who meet the corresponding application conditions were reviewed and enrolled in the group.
After the doctor’s advice, they used 24 boxes (6 months dosage) of Nine Phase One® for treatment.
All the materials were reviewed and approved by the foundation, and they can support up to 12 boxes (3 months dosage).
The ninth phase 1 ® is divided into 3 times for assistance, which can be picked up at the designated stores of the National Center of Pharmacy and Sipai Pharmacy
.
There are more than 160 Yuanxin Pharmacies and Sipai Pharmacy stores across the country to support this "Jiu Jiu Care" project, and patients in the group can go to the designated pharmacy stores to receive assistance medicines
.
Patients can search the WeChat public account "Alzheimer's disease patient charity assistance project" or call 4009008026 to consult the group "China Primary Health Care Foundation"; search the WeChat public account "Hongmian Public Welfare Foundation" or call 4006622971 for consultation.
Group "Kapok Public Welfare Foundation" for the project
.
.
Patients can search the WeChat public account "Alzheimer's disease patient charity assistance project" or call 4009008026 to consult the group "China Primary Health Care Foundation"; search the WeChat public account "Hongmian Public Welfare Foundation" or call 4006622971 for consultation.
Group "Kapok Public Welfare Foundation" for the project
.
For more project details, please see
For more project details, please seereferences
references 1.
Long fei Jia, Yi feng Du, Lan Chu, et al.
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults 60 years or older in China: a cross-sectional study[J].
The Lancet Public Health, 2020, 5(12):661-671.
Long fei Jia, Yi feng Du, Lan Chu, et al.
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults 60 years or older in China: a cross-sectional study[J].
The Lancet Public Health, 2020, 5(12):661-671.
2.
Jia J, et al.
Alzheimer's & dementia.
2018 Apr;14(4):483-491
Jia J, et al.
Alzheimer's & dementia.
2018 Apr;14(4):483-491 1.
2 million high- priced drugs do not wait, Magnesium Health helps direct payment of claims to solve the last mile of patient medication
